CA946374A - 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT - Google Patents

17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT

Info

Publication number
CA946374A
CA946374A CA087,965A CA87965A CA946374A CA 946374 A CA946374 A CA 946374A CA 87965 A CA87965 A CA 87965A CA 946374 A CA946374 A CA 946374A
Authority
CA
Canada
Prior art keywords
beta
alpha
compound
androsta
trien
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA087,965A
Other languages
English (en)
Other versions
CA87965S (en
Inventor
Pieter Westerhof
Lucas Morsink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Application granted granted Critical
Publication of CA946374A publication Critical patent/CA946374A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA087,965A 1969-07-16 1970-07-13 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT Expired CA946374A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3586169 1969-07-16

Publications (1)

Publication Number Publication Date
CA946374A true CA946374A (en) 1974-04-30

Family

ID=10382363

Family Applications (1)

Application Number Title Priority Date Filing Date
CA087,965A Expired CA946374A (en) 1969-07-16 1970-07-13 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT

Country Status (13)

Country Link
US (1) US3723482A (fr)
JP (2) JPS4813540B1 (fr)
BE (1) BE753458A (fr)
CA (1) CA946374A (fr)
CH (2) CH542832A (fr)
DE (1) DE2034333A1 (fr)
ES (1) ES381764A1 (fr)
FR (1) FR2059516B1 (fr)
GB (1) GB1266361A (fr)
IL (1) IL34910A (fr)
NL (1) NL7010302A (fr)
SE (1) SE362643B (fr)
ZA (1) ZA704380B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH428720A (de) * 1958-04-12 1967-01-31 Philips Nv Verfahren zur Herstellung neuer Steroide
GB1012794A (en) * 1962-05-11 1965-12-08 Thomas Dudley Threadgold New steroids and methods of producing same
US3198792A (en) * 1962-06-12 1965-08-03 Philips Corp 10alpha methyl, 9beta hormonal steroids
BE667121A (fr) * 1964-10-28

Also Published As

Publication number Publication date
DE2034333A1 (de) 1971-01-28
JPS4813541B1 (fr) 1973-04-27
BE753458A (fr) 1971-01-14
IL34910A0 (en) 1970-09-17
ZA704380B (en) 1972-02-23
FR2059516A1 (fr) 1971-06-04
CH540238A (de) 1973-08-15
CH542832A (de) 1973-11-30
SE362643B (fr) 1973-12-17
GB1266361A (fr) 1972-03-08
US3723482A (en) 1973-03-27
IL34910A (en) 1973-06-29
FR2059516B1 (fr) 1973-06-08
ES381764A1 (es) 1973-04-16
NL7010302A (fr) 1971-01-19
JPS4813540B1 (fr) 1973-04-27

Similar Documents

Publication Publication Date Title
CA927394A (en) Substituted guanidines, compositions and method of preparation
CA968273A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING M-TYROSINE AND .alpha.-HYDRAZINO-3,4-DIHYDROXYPHENYLPROPIONIC ACID
CA946374A (en) 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT
CA1008461A (en) 3,4-dihydroxyphenyl-alamines as active ingredients of antioxidant compositions
CA960655A (en) N(6)-aralkyl adenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
AU471022B2 (en) Pharmaceutical compositions containing 3-hydroxy-5-pregnane 11, 2-dione
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
CA815003A (en) 9.beta., 10.alpha.-STEROIDS, METHODS OF PRODUCING THESE PRODUCTS, INTERMEDIATES THEREFORE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE NEW COMPOUNDS AS AN ACTIVE INGREDIENT
CA931953A (en) 2,(2',6'-dichlorophenyl)1,3-thiazine-4-one, methods of producing the said substance and preparations containing it as an active ingredient
CA874437A (en) 18-METHYL-9.beta.,10.alpha.-STEROIDS OF THE ANDROSTANE SERIES, METHODS OF PRODUCING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE INGREDIENTS AND METHODS OF PRODUCING THE SAID PREPARATIONS
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
CA807142A (en) 9.beta.,10.alpha.-STEROIDS, METHODS OF PRODUCING THE SAME, PHARMACEUTIC PREPARATIONS CONTAINING SAID 9.beta.,10.alpha.-STEROIDS AS ACTIVE SUBSTANCES AND METHODS OF PRODUCING SAID PREPARATIONS
NL139239B (nl) Werkwijze voor de bereiding van anti-inflammatoire en analgetische preparaten, die als werkzame verbinding 1,2-difenyl-4-gesubstitueerde pyrazolidinedionen-3,5 bevatten, aldus verkregen gevormde preparaten, en werkwijze voor de bereiding van de daarin toegepaste actieve verbindingen.
CA769021A (en) 9.beta.,10.alpha.-STEROIDS, METHODS OF PRODUCING SAID COMPOUNDS AND METHODS OF PRODUCING PHARMACEUTIC PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE CONSTITUENTS AND SAID PREPARATIONS
CA851190A (en) Sulphonyl-ureas and sulphonyl-semicarbazides, preparation thereof and pharmaceutical compositions
CA776679A (en) Urazole compounds, pharmaceutical compositions containing same, and process of administering same
CA838088A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 5((.alpha.,.alpha.,.alpha.,-TRIFLUORO-M-TOLYLOXY)-METHYL)-2-OXAZOLIDINETHIONE
CA937929A (en) PREPARATION OF 5.alpha.-PREGNANE-16.alpha.-ACYLAMIDO-3.beta.,17.alpha.-DIOL-11,20-DIOANE-3-ACYLATES
CA819719A (en) 17.beta.-HALO-16.alpha.-(2-OXOALKYL)-17-ISOPREGNANES AND PREPARATION THEREOF
AU425534B2 (en) Novel gona-4, 9, 11-trienes, processes for their preparation, and pharmaceutical compositions incorporating them
AU449767B2 (en) New acetamidines, processes for their preparation, and pharmaceutical compositions incorporating same
CA827661A (en) PROCESS FOR THE PREPARATION OF 17-SUBSTITUTED-10.beta.-METHYL-D-HOMO-C-NOR-5.alpha.,13.alpha.-GONAN-3-ONES AND POLYDEHYDRO DERIVATIVES THEREOF
CA844580A (en) Pharmaceutical compositions having central activity
AU454701B2 (en) New urea derivatives, a method of producing them and preparations which contain the new substances as active ingredients
AU273358B2 (en) 6, 7-benzmorphan derivatives and pharmaceutical compositions containing thesame